Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system. Scientists at Scripps Research and collaborators have now uncovered how our innate immune system—the ...
Jul 8, 2022
0
70
Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).
Jul 1, 2022
0
3
HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers ...
Jun 30, 2022
0
263
LGBTQ Pride Month is celebrated each June to recognize the impact that lesbian, gay, bisexual, transgender, queer or gender-nonconforming people have had, and continue to have, on society. While millions may celebrate, many ...
Jun 29, 2022
0
15
Testing for HIV suffered a sharp setback during the first year of the pandemic, new government data shows.
Jun 27, 2022
0
19
Many male couples in the U.S. seem to be underestimating the effectiveness of HIV pre-exposure prophylaxis (PrEP) for HIV prevention, and educating partners together could improve the number of male couples who decide to ...
Jun 17, 2022
0
6
During the early days of the COVID-19 pandemic, many people turned to their pets to help them feel less lonely and isolated. Researchers at the University of California, Davis, wanted to learn what role pets played in helping ...
Jun 15, 2022
0
55
A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than ...
Jun 15, 2022
0
28
The province of Saskatchewan leads the country in preventable, opportunistic illnesses enabled by poverty. With new changes to income support programs and increased housing instability, things are getting worse.
Jun 15, 2022
0
11
The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, "4-in-1" fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine, lopinavir, ...
Jun 14, 2022
1
7
